Janssen Biotech, Inc Company Profile
✉ Email this page to a colleague
Biologic Drugs for Janssen Biotech, Inc
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 10,031,144 | 2031-02-15 | Patent claims search |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 10,058,440 | 2025-05-24 | Patent claims search |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 10,064,856 | 2028-01-09 | Patent claims search |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 10,070,977 | 2025-05-24 | Patent claims search |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 10,093,732 | 2028-11-25 | Patent claims search |
Janssen Biotech, Inc. | REOPRO | abciximab | Injection | 103575 | 10,111,968 | 2032-02-15 | Patent claims search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.